McLeod HL - Search Results

1

Pharmacogenetics: using DNA to optimize drug therapy.

Lanfear DE, McLeod HL. Lanfear DE, et al. Among authors: mcleod hl. Am Fam Physician. 2007 Oct 15;76(8):1179-82. Am Fam Physician. 2007. PMID: 17990842 Free article. Review.

2

Beta2-adrenergic receptor genotype predicts survival: implications and future directions.

Lanfear DE, Spertus JA, McLeod HL. Lanfear DE, et al. Among authors: mcleod hl. J Cardiovasc Nurs. 2006 Nov-Dec;21(6):474-7. doi: 10.1097/00005082-200611000-00011. J Cardiovasc Nurs. 2006. PMID: 17293738 Review.

3

Genetic variation in the B-type natiuretic peptide pathway affects BNP levels.

Lanfear DE, Stolker JM, Marsh S, Rich MW, McLeod HL. Lanfear DE, et al. Among authors: mcleod hl. Cardiovasc Drugs Ther. 2007 Feb;21(1):55-62. doi: 10.1007/s10557-007-6007-5. Epub 2007 Mar 3. Cardiovasc Drugs Ther. 2007. PMID: 17340039

4

Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome.

Lanfear DE, Jones PG, Marsh S, Cresci S, Spertus JA, McLeod HL. Lanfear DE, et al. Among authors: mcleod hl. Am Heart J. 2007 Sep;154(3):561-6. doi: 10.1016/j.ahj.2007.04.059. Am Heart J. 2007. PMID: 17719307

5

Caution with beta1-adrenergic receptor genotyping.

Lanfear DE, Marsh S, McLeod HL. Lanfear DE, et al. Among authors: mcleod hl. Clin Pharmacol Ther. 2004 Aug;76(2):185-6; author reply 186. doi: 10.1016/j.clpt.2004.04.007. Clin Pharmacol Ther. 2004. PMID: 15289795 No abstract available.

6

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.

Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. Lanfear DE, et al. Among authors: mcleod hl. JAMA. 2005 Sep 28;294(12):1526-33. doi: 10.1001/jama.294.12.1526. JAMA. 2005. PMID: 16189366

7

Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans.

Lanfear DE, Marsh S, Cresci S, Shannon WD, Spertus JA, McLeod HL. Lanfear DE, et al. Among authors: mcleod hl. J Am Coll Cardiol. 2004 Jul 7;44(1):165-7. doi: 10.1016/j.jacc.2004.03.053. J Am Coll Cardiol. 2004. PMID: 15234427 Free article.

8

Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.

Cresci S, Jones PG, Sucharov CC, Marsh S, Lanfear DE, Garsa A, Courtois M, Weinheimer CJ, Wu J, Province MA, Kelly DP, McLeod HL, Spertus JA. Cresci S, et al. Among authors: mcleod hl. Pharmacogenomics. 2008 Oct;9(10):1403-17. doi: 10.2217/14622416.9.10.1403. Pharmacogenomics. 2008. PMID: 18855529 Free PMC article.

9

Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure.

Lanfear DE, Marsh S, Cresci S, Spertus JA, McLeod HL. Lanfear DE, et al. Among authors: mcleod hl. Pharmacogenomics. 2004 Jul;5(5):553-8. doi: 10.1517/14622416.5.5.553. Pharmacogenomics. 2004. PMID: 15212591

10

Cancer pharmacogenetics.

Marsh S, McLeod HL. Marsh S, et al. Among authors: mcleod hl. Br J Cancer. 2004 Jan 12;90(1):8-11. doi: 10.1038/sj.bjc.6601487. Br J Cancer. 2004. PMID: 14710198 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters